Related Experiment Video
Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug Development
1CNPP/University of Kinshasa, Kinshasa, Kinshasa, Congo (The Democratic Republic of the).
Background:
Many studies in Western countries have examined the association between neuropsychiatric symptoms (NPS) and cognitive functions in dementia, primarily focusing on Alzheimer's disease (AD). However, few studies have evaluated this association in Sub-Saharan African countries. This study examines the association between NPS and cognitive functions in older adults with probable AD in Kinshasa, Congo (DRC).
Method:
A total of 1432 participants were recruited by convenience sampling in Kinshasa, DRC. They underwent the CSID and the AQ. Out of these, 114 participants were retained, including 56 considered to have probable AD and 58 considered to have normal cognition. The two groups were matched by sex, age, and education level. The Neuropsychiatric Inventory (NPI) was used to determine psychiatric symptoms, and the African Neuropsychology Battery (ANB) for cognitive functions. Descriptive statistics, including means, standard deviations, and frequencies, were conducted. The association between NPS and cognitive function was established using multiple linear regression.
Result:
The most frequent NPS were irritability (56%), anxiety (46%), sleep disturbance (44%), depression (42%), appetite disorders (35%), aberrant motor behavior (21%), and agitation (19%). A statistically significant association was found between anxiety and the proverb test (95% CI, p=0.03), and between sleep disturbance and visuospatial memory (95% CI, p=0.05). A trend of association was observed between anxiety and visuospatial memory (95% CI, p=0.06).
Conclusion:
Some NPS are part of the manifestations of AD and are associated with specific cognitive functions. This highlights the importance of using the NPI and ANB in the diagnosis of probable AD.
More Related Videos
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
Related Concept Videos
Preclinical Development: Overview
Clinical Trials: Overview
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Regulation